Clinical Trial Update: Reaching and Treating Lesbian, Gay, Bisexual, and Transgender (LGBT) Cigarette Smokers [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial sponsored by the University of California, San Francisco aimed at reaching and treating LGBT cigarette smokers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cigarette Smoking

Snippet

Sponsor: University of California, San Francisco | Conditions: Cigarette Smoking | Phase 2, Phase 3 | Status: COMPLETED